Company profile: Ness Therapeutics
1.1 - Company Overview
Company description
- Provider of biotechnology aimed at preventing respiratory viruses.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Ness Therapeutics
Okogen
HQ: United States
Website
- Description: Provider of ophthalmic anti-infective drug candidates, including OKG-0303, a fixed-dose combination eyedrop for acute infectious conjunctivitis that combines an antiviral, ocular decongestant, and antibacterial; OKG-0301, an antiviral shown to inhibit viral replication in adenoviral conjunctivitis; and the RUBY trial evaluating the safety and efficacy of OKG-0301.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Okogen company profile →
Evaxion Biotech
HQ: Denmark
Website
- Description: Provider of AI-immunology™ platform-driven immunotherapies for cancer and infectious diseases, including EVX-01, a Phase 2 personalized cancer vaccine targeting patient-specific tumor antigens, and EVX-B1, a vaccine antigen against Staphylococcus Aureus, plus models PIONEER™, ObsERV™, and AI-DEEP™ for vaccine design and CPI response prediction.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Evaxion Biotech company profile →
DDL
HQ: The Netherlands
Website
- Description: Provider of diagnostic solutions in molecular virology, bioinformatics, molecular bacteriology, and pathology, supporting clinical trials globally across five continents. Offers infectious disease and vaccine development expertise, oncology trial support, rare disease cell and gene therapy operations, biologics and biosimilars services from preclinical to post-market, and customized kit building for sample integrity.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full DDL company profile →
Siga Technologies
HQ: United States
Website
- Description: Provider of antiviral therapeutics for lethal pathogens, specializing in smallpox. Products include TPOXX (Tecovirimat-SIGA), approved for treatment of smallpox and, in various regions, monkeypox, cowpox, and vaccinia complications, and TPOXX Injection, an intravenous formulation for smallpox patients unable to swallow oral capsules.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Siga Technologies company profile →
Friz Biochem
HQ: Germany
Website
- Description: Provider of advanced electronic biochips and offerings integrating the complete workflow of molecular diagnostics; privately held, founded in October 2004 and based in Neuried near Munich.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Friz Biochem company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Ness Therapeutics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Ness Therapeutics
2.2 - Growth funds investing in similar companies to Ness Therapeutics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Ness Therapeutics
4.2 - Public trading comparable groups for Ness Therapeutics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →